본문으로 건너뛰기
← 뒤로

Reshaping the immunosuppressive niche in hepatocellular carcinoma: crosstalk networks, metabolic reprogramming, and therapeutic strategies.

Biochemical pharmacology 2026 Vol.248() p. 117858 🌐 cited 1 Hepatocellular Carcinoma Treatment a
TL;DR This review integrates recent advances in understanding the multifaceted mechanisms of immune evasion in HCC, including dysregulated immune cell interactions, metabolic adaptations that reshape immune function, and early activation of inhibitory checkpoints to provide a foundational framework for advancing strategies to overcome HCC's immunosuppressive ecosystem.
OpenAlex 토픽 · Hepatocellular Carcinoma Treatment and Prognosis Cancer, Hypoxia, and Metabolism Liver physiology and pathology

Zhang Y, Xiong S, Zheng W, Liu J, Zhao Y, Lv J, Zhang Y, Guo L, Liang T

📝 환자 설명용 한 줄

This review integrates recent advances in understanding the multifaceted mechanisms of immune evasion in HCC, including dysregulated immune cell interactions, metabolic adaptations that reshape immune

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Yuting ZHANG, Shizheng Xiong, et al. (2026). Reshaping the immunosuppressive niche in hepatocellular carcinoma: crosstalk networks, metabolic reprogramming, and therapeutic strategies.. Biochemical pharmacology, 248, 117858. https://doi.org/10.1016/j.bcp.2026.117858
MLA Yuting ZHANG, et al.. "Reshaping the immunosuppressive niche in hepatocellular carcinoma: crosstalk networks, metabolic reprogramming, and therapeutic strategies.." Biochemical pharmacology, vol. 248, 2026, pp. 117858.
PMID 41794264

Abstract

The liver tumor microenvironment plays a pivotal role in hepatocellular carcinoma (HCC) progression by fostering immune suppression, which impairs anti-tumor responses and enables tumor growth, invasion, and metastasis. This review integrates recent advances in understanding the multifaceted mechanisms of immune evasion in HCC, including dysregulated immune cell interactions, metabolic adaptations that reshape immune function, and early activation of inhibitory checkpoints. Key contributors such as regulatory immune subsets and stromal elements are examined, alongside emerging insights into pre-metastatic niches and metabolic barriers. The review also evaluates current immunotherapeutic approaches targeting these mechanisms, highlighting clinical progress, challenges, and opportunities for precision interventions. By synthesizing these elements, this work provides a foundational framework for advancing strategies to overcome HCC's immunosuppressive ecosystem.

MeSH Terms

Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Tumor Microenvironment; Animals; Immunotherapy; Metabolic Reprogramming

같은 제1저자의 인용 많은 논문 (5)